FIA
CDNA icon

FNY Investment Advisers’s CareDx CDNA Stock Holding History

FNY Investment Advisers’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,133
Closed -$31K – 999
2025
Q3 		$31K Buy
+2,133
New +$30.4K 0.01% 605
2021
Q4 		– Sell
-5,000
Closed -$316K – 585
2021
Q3 		$316K Buy
+5,000
New +$381K 0.15% 118

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

FNY Investment Advisers's CDNA Position: Q4 2025 in Review

FNY Investment Advisers sold out of CareDx (CDNA) in Q4 2025, closing a stake of 2,133 shares — an estimated $31K sold.

FNY Investment Advisers first reported a position in CDNA in Q3 2021 and held it in 2 quarters. The position peaked at $316K in Q3 2021. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • FNY Investment Advisers reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 2,133 CareDx shares in Q4 2025, an estimated $31K.
  • FNY Investment Advisers first reported a position in CareDx in Q3 2021 and held it in 2 quarters.
  • FNY Investment Advisers's CareDx position peaked at $316K in Q3 2021.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.